Cosmetic Adverse Event Reports Spiked 56% In Fiscal 2014 – FDA
This article was originally published in The Rose Sheet
Executive Summary
According to FDA’s Office of Cosmetics and Colors, the number of cosmetic adverse events reported to the agency reached 491 in fiscal 2014, a 56% increase over fiscal 2013. FDA reps say the agency’s data can be deceptive and the total number likely would be higher if cosmetic adverse-event reporting were mandatory.
You may also be interested in...
To Improve Adverse Event Tracking, FDA Could Google It
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.
In Brief: Contamination Recall; ‘Made In America’ Questioned; More
Contract manufacturer Sensible Organics recalls Nourish Organic facial skin-care items due to potential contamination; Revlon's "Almay Simply American" marketing comes under fire for alleged deception. More news in brief.
FDA Cites Adulteration In Warning Letter To Juice Beauty Manufacturer
FDA’s latest warning letter to a cosmetics firm departs from the agency’s crackdown on drug-like structure/function claims, targeting contract manufacturer Gemdo Cosmetics for facility conditions and evidence of microbial contamination that cause its products to be adulterated under the Federal Food, Drug and Cosmetic Act. In the April 16 letter, FDA cites eye products produced at the firm’s plant, including Juice Beauty offerings subject to a July 2014 recall.